Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Platelet Biogenesis is an allogeneic cell therapy company that focuses on platelet biology.
A private biopharmaceutical company .
Bolt Biotherapeutics is a biotechnology company that develops a platform for cancer immunotherapy.
Telomere Therapeutics is a University of Barcelona spinoff developing telomerase gene therapy to treat pulmonary fibrosis
Fortis Therapeutics is an immuno-oncology biotech focused on developing new antibody drug conjugate therapies against CD46.
MiiMOSA operates a crowd funding platform dedicated to agriculture and food.
Satsuma Pharmaceuticals is a clinical-stage biopharmaceutical company engaged in developing a novel therapeutic product.
InnoCare is a Chinese biopharmaceutical company that develops treatment for cancer and autoimmune diseases.
Design Therapeutics is a biotechnology company developing a new class of therapies for serious degenerative disorders.
Passage Bio is a fully integrated gene therapy company developing therapies for the treatment of monogenic central nervous system diseases.
Kira Pharmaceuticals is a Biotechnology Research Company.
Homology Medicines is a genetic medicines company dedicated to transforming the lives of patients suffering from rare genetic diseases.
PatientPop is the only complete practice growth solution that empowers healthcare providers to thrive in the digital age.
Citrine Medicine is a rare disease-focused pharmaceutical firm.
Telum Therapeutics is a biotechnology company.
Tranquis Therapeutics is focused on the discovery and development of therapies to treat neurodegenerative and aging-related diseases.
Leader in true multi-omic spatial sequencing
Genetron Health is a world-leading expert in precision medicine.
Metacrine is a clinical-stage bio pharmaceutical company focused on building an innovative pipeline of best-in-class drugs.
Medeor Therapeutics is a biotechnology company that dedicates to dedicates to the development of personalized cellular immunotherapies.
Outpost Medicine is a biopharmaceutical company
Vivo Capital has invested in 165 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Vivo Capital's top investment sectors include Biotechnology, Pharmaceutical, Health Care, Medical, Therapeutics. The firm invests across 22 different industry categories.
Among tracked funding rounds, Passage Bio received $154.0M in a Post Ipo Equity round. Vivo Capital's total known invested capital is $18.1B.
Vivo Capital's average investment size is $138.9M across its portfolio of 165 companies.
Recent Vivo Capital portfolio additions include Platelet BioGenesis, Neurogastrx, Bolt Biotherapeutics, Telomere Therapeutics, Fortis Therapeutics. These companies were founded in 2020 or later.